[go: up one dir, main page]

TW200509904A - Use of substituted chromans or thiocromans for the treatment of IBS - Google Patents

Use of substituted chromans or thiocromans for the treatment of IBS

Info

Publication number
TW200509904A
TW200509904A TW093116445A TW93116445A TW200509904A TW 200509904 A TW200509904 A TW 200509904A TW 093116445 A TW093116445 A TW 093116445A TW 93116445 A TW93116445 A TW 93116445A TW 200509904 A TW200509904 A TW 200509904A
Authority
TW
Taiwan
Prior art keywords
thiocromans
ibs
treatment
substituted
substituted chromans
Prior art date
Application number
TW093116445A
Other languages
Chinese (zh)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200509904A publication Critical patent/TW200509904A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

The present invention relates to the use of substituted 3-amino chromans or thiocromans as well as enantiomers and salts thereof for the treatment of irritable bowel syndrome (IBS).
TW093116445A 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of IBS TW200509904A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301795A SE0301795D0 (en) 2003-06-19 2003-06-19 New use I

Publications (1)

Publication Number Publication Date
TW200509904A true TW200509904A (en) 2005-03-16

Family

ID=27607360

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093116445A TW200509904A (en) 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of IBS

Country Status (4)

Country Link
AR (1) AR044717A1 (en)
SE (1) SE0301795D0 (en)
TW (1) TW200509904A (en)
WO (1) WO2004110429A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
ATE151419T1 (en) * 1991-02-08 1997-04-15 Lilly Co Eli RING-SUBSTITUTED 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALINES
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE510305C2 (en) * 1997-05-30 1999-05-10 Astra Ab Fresh salt

Also Published As

Publication number Publication date
WO2004110429A1 (en) 2004-12-23
SE0301795D0 (en) 2003-06-19
AR044717A1 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
EA200601553A1 (en) SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES
UA86591C2 (en) Pyrrolodihydroisoquinolines as pde10 inhibitors, pharmaceutical composition based thereon
EA200601555A1 (en) Substituted indazole-glucosides
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
EA200601554A1 (en) SUBSTITUTED INDOL-O-GLUCOSIDES
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
UA83875C2 (en) Quinoline derivatives for use as mycobacterial inhibitors
EA200601552A1 (en) SUBSTITUTED CONDENSED HETEROCYCLIC C-GLYCOSIDES
DK1682530T3 (en) Pyrrole-substituted indoles as inhibitors of PAI-1
EA201001481A1 (en) Derivatives of tertiary amine as inhibitors of phosphodiesterase-4
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
NO20043952L (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyperproliferative disorders
WO2006034113A3 (en) Quinolone analogs as cell proliferation inhibitors
DE60316984D1 (en) BENZOYLSULFONAMIDE AS ANTITUMOR MEDIUM
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
AP1543A (en) Phenyl heterocyclyl ethers.
TW200616977A (en) Enantiomers of selected fused heterocyclics and uses thereof
DE60316128D1 (en) N-sulfonylurea APOPTOSIS PROMOTERS
ATE542796T1 (en) N-SULFONYLCARBOXIMIDAMIDE COMPOUNDS AS APOPTOSIS PROMOTERS
EA200600601A1 (en) AMINOPYRIDINE DERIVATIVES AS AN INDUCED NO SYNTHASE INHIBITORS
GB0407025D0 (en) Novel compounds
AU2003281220A1 (en) N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/ or serotonin reuptake inhibitors
DE60211495D1 (en) XANTHINE-GLYCOL DERIVATIVES FOR THE TREATMENT OF REIZDARY SYNDROME